|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$142.80 |
$144.25 |
$140.72 |
$142.17 |
299.40K | 04/18/2024 |
$143.00 |
$143.67 |
$140.23 |
$140.89 |
222.20K | 04/19/2024 |
$141.39 |
$144.41 |
$137.78 |
$140.17 |
280.70K | 04/22/2024 |
$140.48 |
$144.33 |
$140.41 |
$142.10 |
245.70K | 04/23/2024 |
$143.30 |
$147.45 |
$143.30 |
$144.83 |
220.10K |
|
Ascendis Pharma is a biopharmaceutical company. Co.'s primary investigational product candidate, TransCon Growth Hormone, is in development as a once-weekly prodrug of recombinant human growth hormone as a potential treatment for pediatric growth hormone deficiency. Co. is also using its TransCon technologies to develop other product candidates to address rare endocrine diseases. These product candidates include TransCon Parathyroid Hormone as a potential treatment for adult hypoparathyroidism and TransCon C-Type Natriuretic Peptide as a potential therapeutic option for achondroplasia, the most common form of dwarfism. | |
|
Ascendis Pharma A/S (ASND) has the following price history information. Looking back at ASND historical stock prices for the last five trading days, on April 17, 2024, ASND opened at $142.80, traded as high as $144.25 and as low as $140.72, and closed at $142.17. Trading volume was a total of 299.40K shares. On April 18, 2024, ASND opened at $143.00, traded as high as $143.67 and as low as $140.23, and closed at $140.89. Trading volume was a total of 222.20K shares. On April 19, 2024, ASND opened at $141.39, traded as high as $144.41 and as low as $137.78, and closed at $140.17. Trading volume was a total of 280.70K shares. On April 22, 2024, ASND opened at $140.48, traded as high as $144.33 and as low as $140.41, and closed at $142.10. Trading volume was a total of 245.70K shares. On April 23, 2024, ASND opened at $143.30, traded as high as $147.45 and as low as $143.30, and closed at $144.83. Trading volume was a total of 220.10K shares.
ASND Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ascendis Pharma A/S shares, starting with a $10,000 purchase of ASND, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/29/2015 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$20.00 |
|
End price/share: |
$144.83 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
624.15% |
|
Average Annual Total Return: |
23.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$72,426.02 |
|
Years: |
9.24 |
|
|
|
Date |
Close |
04/17/2024 | $142.17 | 04/18/2024 | $140.89 | 04/19/2024 | $140.17 | 04/22/2024 | $142.10 | 04/23/2024 | $144.83 |
|
|